Scott Glenn Insider Profile

4 Followers
Scott Glenn, Director at Evoke Pharma, holds 40.85K shares in Evoke Pharma (Ticker: EVOK), holds 476.56K shares in Dexcom (Ticker: DXCM), holds 143.85K shares in Santarus (Ticker: SNTS).
tipranks
Scott Glenn

Scott Glenn
Evoke Pharma (EVOK)
Director

Not Ranked
Scott Glenn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34M
99.31%
0.69%
A breakdown of Scott Glenn's holdings

Insider Roles

Dexcom
(DXCM)
Ten Percent Owner
Evoke Pharma
(EVOK)
Director
Roles that Scott Glenn holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Scott Glenn

Scott Glenn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Evoke Pharma
Oct 02, 2013
Director
Uninformative Buy
$230.83K
Dexcom
Ten Percent Owner
$33.34M
SNTS
Santarus
SOMX
Somaxon Pharmaceuticals
List of latest transactions for each holding click on a transaction to see Scott Glenn's performance on stock

Scott Glenn insider profile FAQ

What is the percentage of profitable transactions made by Scott Glenn?
The percentage of profitable transactions made by Scott Glenn is ―.
    What is the average return per transaction made by Scott Glenn?
    The average return per transaction made by Scott Glenn is ―.
      What stocks does Scott Glenn hold?
      Scott Glenn holds: EVOK, DXCM, SNTS, SOMX stocks.
        What was Scott Glenn’s latest transaction?
        Scott Glenn latest transaction was an Uninformative Buy of ―.
          What was Scott Glenn's most profitable transaction?
          Scott Glenn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Scott Glenn's role in Evoke Pharma?
            Scott Glenn's role in Evoke Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.